Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Signs MoUs with Shri Krishna Ayush University and Dabur India
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Acquisition includes Restoret, a novel late-phase candidate for diabetic macular edema and neovascular age-related macular degeneration
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
Global Initiative on Digital Health (GIDH) was launched by the WHO and the Government of India during the G20 Health Working Group meeting in Gandhinagar last year
Pelabresib recently met its primary endpoint of spleen volume reduction and demonstrated favorable trends in symptom improvement
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Subscribe To Our Newsletter & Stay Updated
